imatinib (Numedicus)

N/A

Report date: 2026/04/07 20:00:20

Base Information

Drug Nameimatinib (Numedicus)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet-derived growth factor receptor inhibitorsBcr-Abl tyrosine kinase inhibitorsStem cell growth factor receptor inhibitors
TargetsPlatelet-derived growth factor receptorBcr-Abl tyrosine kinaseStem cell growth factor receptor
Therapy Area/IndicationsRespiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNumedicus Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNumedicus Ltd
Active IndicationsN/A
Inactive IndicationsRespiratory Distress Syndrome, Adult

Other Information

ATC CodeN/A
Related LinksN/A